- PID
- 3101726
EGgel S Plus
For over a decade, ENGAIN has built a diverse and robust medical device portfolio driven by our proprietary polymer synthesis technology. Specializing in gelatin and NBCA-based biomaterials, we are dedicated to providing cutting-edge solutions designed to maximize physician convenience and accelerate patient recovery. Backed by 10 years of proven expertise, discover our core product lineup recognized for its clinical excellence and global standards.
- Certification
-
- Award
-
- Shipping
-
- Lead Time28 ~ 28days
- Type of Freight Proceed after consultation
- Modes of Transport EXW
- Products Shipped From Incheon
- Payment
-
140+ Global Payments, trusted and secure payment provided by PayVerse.
Learn More
- Quantity
- MOQ : 5 Cartons
Detailed Description
EGgel S Plus: Premium Biocompatible Embolic Agent
EGgel S Plus is a highly advanced embolic agent formulated from virus-inactivated porcine gelatin. Boasting exceptional biocompatibility, it is completely non-immunogenic and non-pyrogenic. With approximately 180,000 units sold, its clinical efficacy and safety have been rigorously proven, allowing it to capture the majority of the market share in Korea and distribute widely across Southeast Asia.
• Versatile Clinical Application: Primarily utilized for Transarterial Chemoembolization (TACE) in Hepatocellular Carcinoma (HCC) patients. Depending on the particle size, it is also highly effective for treating Postpartum Hemorrhage (PPH) and serving as a biopsy plugging material.
• Precision and Customization: The particles are precisely calibrated to accommodate various blood vessel sizes, offering a comprehensive lineup of 9 distinct models. This ensures excellent deliverability through microcatheters without clogging.
• Optimized Temporary Embolization: It safely degrades within a predictable timeframe, protecting non-target vessels from permanent damage and promoting optimal patient outcomes.
